AQW 49017/22-27

Ms Connie Egan
Alliance Party
North Down

Tabled Date: 18/06/2026
Answered On Date: 15/07/2026
Priority Written: No

Question:
To ask the Minister of Health to detail any steps his Department is taking to reduce diagnostic delays for metastatic breast cancer.

Answer:

Metastatic breast cancer occurs when cancer cells spread from the breast to other parts of the body. Women previously treated for primary breast cancer are recognised as being at increased risk of recurrence, including metastatic disease. They are supported through structured followup arrangements, including a five-year SelfDirected Aftercare (SDA) programme. This provides personalised information on the signs and symptoms of recurrence or metastatic disease, supporting individuals to identify concerns at an early stage and seek reassessment through specialist services.

Referral and triage systems across Health and Social Care are designed to prioritise patients with suspected cancer for rapid review, with suspected cases assessed promptly to facilitate timely diagnostic investigation. Patients within the SDA pathway can access breast assessment services directly through established Trust arrangements without the need for GP referral, supporting streamlined entry to appropriate diagnostic services.

By enabling direct access to specialist assessment and promoting awareness of symptoms, the SDA programme removes additional steps in the pathway and encourages earlier presentation where concerns arise.

In addition, the NICaN Breast Clinical Reference Group is at an early stage in developing a regional metastatic breast cancer pathway. This work aims to standardise care processes, improve awareness and communication of the signs and symptoms of recurrence, and strengthen access to appropriate support services, with the objective of supporting earlier diagnosis and improved patient outcomes.